Although Walker 256 breast tumour cells are less sensitive towards lapatinib because of lower ErbB2 mRNA expression and undetectable ErbB1 mRNA expression, the drug exhibited cytotoxic effect on the cell line, suggesting involvement of other unknown mechanisms which could be an off-target cytotoxic effect [26]. Here, EGFR is linked to breast neoplasm.